These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10350033)

  • 1. Opioid withdrawal during risperidone treatment.
    Wines JD; Weiss RD
    J Clin Psychopharmacol; 1999 Jun; 19(3):265-7. PubMed ID: 10350033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manic and psychotic symptoms following risperidone withdrawal in a schizophrenic patient.
    Lane HY; Chang WH
    J Clin Psychiatry; 1998 Nov; 59(11):620-1. PubMed ID: 9862609
    [No Abstract]   [Full Text] [Related]  

  • 3. Withdrawal-emergent respiratory dyskinesia with risperidone treated with clozapine.
    Mendhekar DN; Inamdar A
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E24. PubMed ID: 20463136
    [No Abstract]   [Full Text] [Related]  

  • 4. Steroid-induced psychosis treated with risperidone.
    DeSilva CC; Nurse MC; Vokey K
    Can J Psychiatry; 2002 May; 47(4):388-9. PubMed ID: 12025444
    [No Abstract]   [Full Text] [Related]  

  • 5. Risperidone and withdrawal dyskinesia.
    Lore C
    J Am Acad Child Adolesc Psychiatry; 2000 Aug; 39(8):941. PubMed ID: 10939219
    [No Abstract]   [Full Text] [Related]  

  • 6. [Risperidone in the treatment of psychotic patients with opiate abuse and dependence].
    Casas M; Gutiérrez M; Gibert J; Bobes J; Roncero C; Octavio I
    Actas Esp Psiquiatr; 2001; 29(6):380-5. PubMed ID: 11730575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of parkinsonian symptoms after discontinuation of carbamazepine in patients concurrently treated with risperidone: two case reports.
    Takahashi H; Yoshida K; Higuchi H; Shimizu T
    Clin Neuropharmacol; 2001; 24(6):358-60. PubMed ID: 11801812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Akathisia due to risperidone withdrawal: two clinical cases].
    Bertolín Guillén JM; Martínez Franco L; Juni Anahuja J
    Actas Esp Psiquiatr; 2002; 30(3):195-7. PubMed ID: 12106521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Relapse After Discontinuation of Antipsychotic Treatment in Alzheimer's Disease: The Role of Hallucinations.
    Patel AN; Lee S; Andrews HF; Pelton GH; Schultz SK; Sultzer DL; Mintzer J; de la Pena D; Gupta S; Colon S; Schimming C; Levin B; Devanand DP
    Am J Psychiatry; 2017 Apr; 174(4):362-369. PubMed ID: 27855483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosis After Switch in Opioid Maintenance Agonist and Risperidone-Induced Pisa Syndrome: Two Critical Incidents in Dual Diagnosis Treatment.
    Sutter M; Walter M; Dürsteler KM; Strasser J; Vogel M
    J Dual Diagn; 2017; 13(2):157-165. PubMed ID: 27935442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rispolept (risperidone) efficacy in the treatment of patients with schizophrenia and psychoactive drug dependence].
    Drozdov ES
    Voen Med Zh; 2002 Jul; 323(7):46-52. PubMed ID: 12192989
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY; Wu PC; Chen CY; Chen YC
    Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence.
    Smelson DA; Losonczy MF; Davis CW; Kaune M; Williams J; Ziedonis D
    Can J Psychiatry; 2002 Sep; 47(7):671-5. PubMed ID: 12355680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withdrawal-emergent rabbit syndrome during dose reduction of risperidone.
    Nishimura K; Tsuka M; Horikawa N
    Eur Neuropsychopharmacol; 2001 Aug; 11(4):323-4. PubMed ID: 11532387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome with risperidone.
    Gleason PP; Conigliaro RL
    Pharmacotherapy; 1997; 17(3):617-21. PubMed ID: 9165568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tics with risperidone withdrawal.
    Rowan AB; Malone RP
    J Am Acad Child Adolesc Psychiatry; 1997 Feb; 36(2):162-3. PubMed ID: 9031567
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neuroleptic malignant syndrome in users of risperidone].
    Bonte-Mineur F; Geerlings CJ; Rietveld AP
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):158-9; author reply 159. PubMed ID: 15693595
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.
    Mullins CD; Obeidat NA; Cuffel BJ; Naradzay J; Loebel AD
    Schizophr Res; 2008 Jan; 98(1-3):8-15. PubMed ID: 17596914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroleptic malignant syndrome in users of risperidone].
    van Bemmel T; Westendorp RG
    Ned Tijdschr Geneeskd; 2005 Mar; 149(11):608; author reply 608. PubMed ID: 15799646
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase-IV multicentre clinical study of risperidone in the treatment of outpatients with schizophrenia. The RIS-CAN-3 Study Group.
    Chouinard G; Kopala L; Labelle A; Beauclair L; Johnson SV; Singh KI
    Can J Psychiatry; 1998 Dec; 43(10):1018-25. PubMed ID: 9868567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.